Rubió is a company dedicated to the development, manufacture and marketing of products with a preferential focus on pharmaceuticals, medical devices and diagnostics in CNS, musculoskeletal, nephrology, urology and cardiovascular risk.

The international portfolio strategy focuses on our main products: Rubifen (Methylphenidate), Resincalcio/Resinsodio (Calcium/Sodium polystyrene sulfonate),Resincolestiramina (Cholestyramine) & Dolquine (Hydroxychloroquine).

We also have OWLiver®, a non-invasive diagnostic approach for the detection of NAFLD/MAFLD in each stage of the disease (from simple steatosis to NASH or NASH plus Fibrosis F>2); Liposcale®, a diagnostic lipoprotein test that provides with a complete metabolic profile to assess cardiovascular risk and, Rubidiet® Nefro, a novel dietary food for special medical uses that focus on malnutrition in renal kidney patients. Besides, Rubió has exclusive worldwide commercial rights for OWLiver®, Liposcale® and Rubidiet® Nefro.